Clinical trial
Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity
NCT00364871 · Orexigen Therapeutics, Inc, Industry · Completed
Key facts
| NCT number | NCT00364871 |
|---|---|
| Title | Efficacy and Safety Study of Combination Therapy to Treat Uncomplicated Obesity |
| Official title | Phase 2, Multicenter, Randomized, Double Blind, Placebo Controlled Study of Combination Therapy for Safety and Efficacy in Subjects With Uncomplicated Obesity |
| Lead sponsor | Orexigen Therapeutics, Inc, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | naltrexone and bupropion SR |
| Enrollment | 410 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Aug 16, 2006 |
| Last update posted | Apr 22, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: